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linkages: mimicking cellular
compartmentalization for the engineering
of functional proteins
Liisa D. van Vliet, Pierre-Yves Colin and Florian Hollfelder
Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK
The idea of compartmentalization of genotype and phenotype in cells is key for
enabling Darwinian evolution. This contribution describes bioinspired systems
that use in vitro compartments—water-in-oil droplets and gel-shell beads—for
the directed evolution of functional proteins. Technologies based on these
principles promise to provide easier access to protein-based therapeutics,
reagents for processes involving enzyme catalysis, parts for synthetic biology
and materials with biological components.1. Introduction
The cell membrane separates molecules belonging to a cell from those that are
part of the environment. A key role of this compartmentalization is to link the
genotype (‘the genetic constitution of an individual’) with its corresponding
phenotype (‘a set of observable characteristics of an individual’). This linkage
is important for Darwinian evolution, as selection is exerted at the level of
the phenotype, but survival and propagation of a selected trait are dependent
on the relevant gene being carried forward to subsequent rounds of evolution.
Both have to be linked to ensure that a selective advantage conferred by a gene
leads to the emergence of improved species.
It can thus be argued that compartmentalization is the organizing principle
that enables Darwinian evolution—and that a cell-like compartment is the most
basic ‘evolutionary unit’. This contribution describes experimental approaches
towards artificial evolution that employ mimics of cellular compartments
(figure 1): water-in-oil emulsions, droplets or gel beads that keep together an iden-
tifier (i.e. a gene), the functional molecule encoded by the gene (i.e. a protein) and
a readout (e.g. an optical signal that distinguishes ‘winners’ from ‘losers’ in an
evolutionary selection round). Such compartments can be made completely
in vitro, so that—despite being inspired by cells—they are reducing the complex-
ity of the cell-like compartment to just one purpose: linking genotype and
phenotype and allowing an assay for the one function of interest. This type of bio-
logical reductionism differs from that originally proposed by Crick (‘to explain all
biology in terms of physics and chemistry’) [4]: instead of a molecular under-
standing of the end products of evolution as the basis for future rational design
of equally perfect or even improved constructs, the features of the engine of evol-
ution are to be controlled, understood and ultimately mimicked: constituting a
system that provides a route towards functional molecules.
The ability to evolve functional proteins is assuming an increasingly central
role, because rational design of protein binders or catalysts often does not pro-
vide efficient solutions, notwithstanding the enormous progress in protein
design over the last two decades. For example, antibodies used in therapy are
routinely generated by ‘directed evolution’ (i.e. combinatorial selections from
large libraries of candidates) and not by design despite a wealth of molecular
insight into protein structure. Although we know so much, for example,







gene, tag, label, dye concentration...
fluorescence, luminescence, absorbance...
Figure 1. An in vitro compartment (a droplet [1,2] or a bead [3]) combines
(a) the function of a molecule (e.g. the catalytic or binding activity of a
protein or nucleic acid). (b) The information on its identity (e.g. its sequence
encoded by DNA) and (c) a readout to assess the molecule’s ability to carry
out its function via a miniaturized assay (e.g. based on product fluorescence).
Droplet diameters vary between 1 and 200 mm (corresponding to volumes






from comprehensive databases of primary sequences and
structures, antibody binders are made by combinatorial
methods (rather than by design in silico). Likewise, compu-
tational designs of catalytic proteins [5,6] often require
further improvement by directed evolution [7,8] and the con-
tribution of directed evolution can exceed the contribution of
design [9]. Of course both approaches—design and selec-
tion—are complementary, and each directed evolution
experiment will provide rational explanations and contribute
in turn to the body of design rules for biological molecules.
However, Crick’s optimism about the supremacy of molecu-
lar design has to be mixed with a dose of realism about its
limits and a realistic strategy for the creation of functional
biomolecules will have to involve library methods and
directed evolution.
Important criteria for a good evolution system are
(i) simple to set up, (ii) allowing high throughput (more
than 106 experiments within a reasonable experimental time-
scale, i.e. hours or days) and, as far as possible, (iii) that
evolution should be preferably conducted in vitro, because
carrying out this process under non-natural conditions can
overcome the following constraints:
— the requirement of having to comply with a working bio-
logical system (e.g. compatibility with a host organism)—
proteins that are toxic to the host cannot be evolved;
— the narrow dynamic range of in vivo selections and
the limit that only proteins directly relevant for survi-
val of the host are amenable to in vivo evolution (e.g. in
auxotrophic selections); and
— in vivo selections cannot be carried out under non-natural con-
ditions, for example, involving the use of non-natural amino
acids, operating at extremes of pH or temperature, or under
other desired non-physiological conditions.
To free directed evolution from these constraints and drive it
by arbitrarily chosen selection criteria (instead of host cell
survival), attention has therefore turned to in vitrocompartments for directed evolution that replace the cell
compartment with a man-made entity that is equally suited
to combine genotype and phenotype.
Joshua Lederberg anticipated the potential of such com-
partments in classical experiments designed to probe the
clonal selection theory [10,11]: by isolating single lymph-
node cells in emulsion droplet compartments, the secreted
antibody was kept together with the cell producing it, thus
providing genotype–phenotype linkage by compartmentali-
zation and permitting assays to test the characteristics of
each secreted protein. These groundbreaking studies pro-
vided evidence for the ‘one cell-one antibody’ rule [12].
Already at the time, Lederberg suggested that such compart-
ments would ‘find routine applications in any laboratory’,
which now, half a century later, is starting to become reality.
The potential of emulsion compartments for molecular
evolution was first explored by Tawfik & Griffiths [13]. To
obtain ‘monoclonal’ compartments (in which one gene and
the corresponding protein encoded by it are unambiguously
linked), a gene library is diluted so that each droplet contains
no more than one member. Encapsulation of particles and
molecules into droplets follows a Poisson distribution. In
order to obtain mainly monoclonal compartments, most of
the droplets are left empty. For example, a suspension con-
taining on average 0.3 entities (DNA molecules or cells) per
droplet results in 74%, 22% and 3% of the droplets containing
none, one or two entities, respectively. The compartmentali-
zation makes very large numbers of experiments possible in
highly parallelized fashion, and also reduces the cost per
assay dramatically (by approx. 106-fold [14]), as the assay
volume is reduced to the femto- to picolitre scale through
use of microdroplets.
Such water-in-oil emulsion compartments can be made in
a number of ways:
— by dispersing an aqueous solution in an oil phase,
which produces approximately 109 polydisperse droplets
(diameter 1–4 mm) in one experiment—which is simply
accomplished with an emulsifier or stirrer—taking only
a few minutes [15–18], or
— in a microfluidic droplet generator by break-off from an
aqueous stream, in which approximately 107 monodisperse
compartments with identical size (typically 10–200 mm,
adjustable as a function of the device design and flow
rates) are produced per hour [15,19,20].
2. Protein display systems generated
in compartments
High-affinity protein binders with defined specificity have
become indispensable reagents in basic research, large-scale
proteomic studies, and also in therapy, where they represent
the fastest growing segment of the pharmaceutical market.
The need for protein binders is addressed by display technol-
ogies [21,22]. For example, in phage display the protein
of interest (POI) is fused to a coat protein, e.g. via the
N-terminus of the minor (pIII) or major (pVIII) capsid pro-
teins (figure 2) [24–26]. Protein expression occurs in vivo,
but subsequent selections are carried out in vitro. It would
be desirable to carry out the entire expression and selection
process under in vitro conditions and generate a robust and
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Figure 2. Comparison of natural and artificial display systems distinguished
by the method of selection [23]. (a) A functional molecule (i.e. a protein of
interest, POI) is connected to a gene encoding it. Selection from a library is
based on binding to an immobilized target molecule: if binding molecules
can be pulled out from a library based on their affinity by such ‘panning’,
the attachment of the coding gene means that the selected clones can be
sequenced. In this process, quantitative and direct control of ligand-binding
parameters are not possible. Further, labour-intensive measurements are
often necessary to assess the strength and specificity of affinity-selected bin-
ders. The natural phage display system is contrasted to in vitro SNAP display.
(b) Yeast display provides multiple copies of the POI, as does its in vitro
equivalent BeSD. Flow cytometry (FACS) measures the number of fluorescently
labelled target molecules bound to the display construct and thus screens
every mutant in the library, allowing a quantitative threshold to be set as






have been demonstrated by comparisons of affinity and
diversity of binders generated in display formats that involve
a host versus in vitro systems [27,28].
In the SNAP display [13,29,30], a display construct
is assembled with the help of an in vitro compartment
(figure 3a). A link between the POI and DNA is brought
about by compartmentalizing a single DNA molecule in
each water-in-oil emulsion microdroplet, expressing the POI
in vitro and retaining both together by the microdroplet
boundary. The corresponding protein is expressed as a
fusion with a protein tag that reacts covalently with a label
on its coding DNA (a benzylguanine (BG) [34] coupled to
DNA) and the droplet compartment keeps gene and cognate
protein together (assuring monoclonality). Inspired by the
linkage of DNA and POI on a phage, the bare-bones
SNAP-display is a reductionist model of the natural phage
display system.
Selections are performed by ‘panning’ under in vitro con-
ditions: the display construct is passed over immobilized
target molecules and the binders stick (with their DNA
attached—and can thus be decoded). These selections are
based on off-rates (koff ) and highly dependent on the con-
ditions employed (e.g. the duration and number of washes in
the panning procedure). Variants are recovered if their affinity
is above a pre-set threshold, but this threshold is not necessarilyprecisely defined (i.e. a function of the experimental protocol
and the operator’s handling).
In a further variation of SNAP display, the ‘panning’ step
is replaced with more quantitative, direct readouts of a
binding constant (KD). When display constructs contain
a larger number of proteins—e.g. approximately 104 copies
displayed on bacteria [35–40] or 30 000 copies on yeast [41]—
selections can be based on the measurement of the number of
bound target molecules (counted by quantification of an optical
label for every clone): flow cytometry is employed to rank and
sort binders. Variation of the concentration of a fluorescent
ligand incubated with the display construct and measurement
of the extent to which it sticks, determines selection pressure
akin to Kd titrations. This ranking gives access to populations
of weaker and stronger binders depending on the chosen fluor-
escence threshold in flow cytometry (figures 2b and 3b).
Inspired by yeast and bacterial display, a megavalent vari-
ation of SNAP display (dubbed BeSD, bead surface display)
provides an in vitro equivalent to the multivalent natural display
systems (figure 2b) [23]. Again, single genes are compartmenta-
lized in emulsion droplets—but now amplification is performed
in the droplet compartment and up to a million copies of DNA
and protein are assembled on a bead in a multi-step procedure.
The compartment is responsible for keeping the cognate gene
and POI together and the resulting construct reminding us of
yeast display, but bears more protein copies and is completely
generated in vitro. Libraries of such constructs can now be ana-
lysed by flow cytometry and binders identified at a throughput
of approximately 107 per hour.
Both SNAP methods avoid shortcomings of in vivo display
systems, e.g. low transformation efficiency, toxicity of the dis-
played protein to the host or lack of display construct stability.3. Selections for enzyme catalysts in
compartments
Instead of providing a template for the genotype–phenotype
linkage that is later used for selection, the droplet compart-
ment can also be maintained until selection, which makes it
eminently suitable for selections of enzyme catalysts. Figure 4
shows how a substrate is co-compartmentalized with the
protein catalyst in a droplet, multiple turnovers occur: now
selections can be carried out based on product detection. To
make product detection as precise as possible, microdroplets
are prepared in monodisperse form in microfluidic devices
(made, for example, conveniently by soft lithography from
polydimethylsiloxane [15,58,59]) and interfaced with analytical
systems. Figure 5 shows building blocks of integrated microflui-
dic devices that have recently been built. Many steps that are
normally carried out in manual laboratory routines by pipetting
are now automated in ‘lab-on-a-chip’ devices that process the
bioinspired cell-like droplets on-chip on an assembly line at
ultra-high throughput. In addition to droplet formation, the
microfluidic format allows a number of other unit operations
that are summarized in figure 4. Droplets are formed at rates
well above 1 kHz [52,60] and can then be divided [44], fused
[45–50], incubated [48,51], analysed [52–55], sorted [14,56,57]
and broken up. An attractive feature of the microfluidic
droplet platform is its modularity, where individual elements
of a workflow correspond to experimental steps that are rep-
resented as jigsaw pieces [43]. Each piece of the jigsaw
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Figure 3. Formats for artificial covalent genotype – phenotype linkages based on droplet compartmentalization. The key initial step of both display methods is that a
DNA library (coding for SNAP-tag-fused variants of the POI) is compartmentalized in water-in-oil emulsion droplets, so that each compartment contains no more
than one DNA template (Poisson distribution). (a) In SNAP display [29 – 33], the POI is in vitro expressed from a single gene in fusion to the SNAP-tag (1). The
SNAP-tag of the expressed fusion protein then reacts with its substrate, BG, that has been covalently linked to the DNA template. As a result, the SNAP-tag connects
genotype and the displayed protein (responsible for the phenotype). (2) SNAP-tagged proteins are de-emulsified and challenged for binding against an antigen by
affinity panning. (3) After non-binders are washed away, binders are eluted together with their encoding genes that can feed the next round of selection. (b) In
BeSD display [23], the DNA is amplified by ePCR (using appropriate labelled primers), captured on the beads via a biotin – streptavidin linkage and the POI is in vitro
expressed. After the emulsion is broken, beads are incubated with the labelled target and the affinity for the target is measured via fluorescence-activated sorting
(FACS). The binding affinity of each recovered variant can be measured by subsequent FACS analysis on the bead display construct. The bead connects genotype and






macroscopic workflow to the miniaturized scale within a micro-
fluidic device. Integration of these steps with control over
timing can potentially create a versatile system for directed
evolution in which complex selection schemes can be realized.
Much recent work has been devoted to meeting the chal-
lenge of integration of the physical droplet processing stepswith standard biological operations that may later be part
of an integrated workflow for directed evolution. First, com-
partmentalization of cells is possible: single bacteria or yeast
cells can be cultivated in droplets and recovered alive [61].
Second, in vitro protein expression from a single template




































Figure 4. A workflow for directed evolution of a hydrolase by lysate screening in droplets [42]. (a) Unit operations from the ‘toolbox’ ( figure 5) are assembled to
miniaturize the steps necessary for single-cell assays of library members for directed evolution. (b) Workflow: (1) the protein of interest (POI), in this case an
enzyme, is expressed in E. coli; (2) single cells are compartmentalized, together with substrate and cell lysis agents; (3) droplets are incubated to generate flu-
orescent product and (4) re-injected into a sorting device, where hits are detected by laser-induced fluorescence and steered into the upper channel by a variable
electric field; (5) plasmid DNA from selected droplets is electroporated into E. coli. Repetition of such cycles increases the stringency of selection and enriches hits






molecule in a droplet) has been demonstrated [51]. Kinetic
parameters for several enzymes were also determined in
microfluidic droplets, providing the facility to evaluate
individual mutants kinetically [53,54].
An entire workflow to miniaturize rounds of directed
evolution is shown in figure 6: in a single-cell lysate protocol
[42], single cells (each cell representing one library member)
were compartmentalized with lysis reagents and substrate,
so that after cell rupture compartmentalized enzymatic reac-
tions catalysed by the protein produced by a single cell can be
monitored, and subsequently sorted. Catalysts can be incubated
in a delay line (with several point measurements) [42] or—for
slow reactions—after offline storage for several days [62]. This
procedure was exemplified by the successful evolution of a
promiscuous hydrolase [42] in two rounds of genetic diversifica-
tion and selection, which led to improved expression and activity
by an order of magnitude each. The genotype–phenotype link-
age provided by the droplet boundary was maintained until
de-emulsification after selection.4. Compartments turned to gel-shell beads:
materials with evolvable components
Natural cells can be considered as incredible examples of
functional materials, because their architecture equips themwith functions of everyday survival, such as converting
foodstuffs to energy, sensing or movement. In addition,
they are vehicles for Darwinian evolution, providing for
long-term development of an organism (or its components)
by selection. By contrast, materials or devices are typically
designed as such, but no mechanism for adaptation is built
in. While future generations of cells will invariably evolve
(e.g. in response to an environmental challenge), man-made
materials will be limited to the original design: improvements
are possible, but the designer has to intervene to specifically
improve its properties.
In an attempt to turn droplet compartments into composite
materials, we devised gel-shell beads (GSBs) that resemble
minimalist versions of a natural cell [3]: a shell surrounds its
interior, where functional molecules and their code (DNA)
are lodged. To this end, microfluidic devices were used to pro-
duce large numbers of cell-sized droplets, which contain agarose
that forms a stable structure (similar to the cytoskeleton): upon
lowering the temperature, additional ingredients—agarose and
alginate—solidify creating agarose microspheres (Ø  25 mm)
in droplets and ‘immortalize’ the monoclonal nature of the
original droplet. Addition of a functional polyelectrolyte
shell with selective permeability (like the semipermeable
cell membrane) completes the synthesis of biomimetic com-
partments. The shell—created by layer-by-layer technology
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Figure 5. Unit operations for generating and handling in vitro compartments [43]. In addition to droplet formation (a), the microfluidic format allows a number of
other unit operations. Droplets can be divided [44], fused [45 – 50], incubated [48,51], analysed [52 – 55], sorted [14,56,57] and broken up. An attractive feature of
this approach is its modularity, where individual elements of a workflow correspond to experimental steps that are represented as jigsaw pieces. Each piece of the






only for molecules less than 2 kDa) that co-compartmentalizes
genotype and phenotype, thereby keeping the coding DNA,
the enzyme and its (fluorescent) reaction product together.
Most importantly, the beads are robust and can be easily
screened/sorted using standard flow cytometry, a feature
that sets GSBs apart from any existing high-throughput
screening system currently available.
As above, single bacteria were encapsulated with substrate
in microdroplets and lysed to liberate the POI and successful
selections of a bioremediation catalyst, a phosphotriesterase,
were carried out [3].
GSBs can be seen as containers for biocatalysts for cost-
effective and sustainable applications that require easy
recovery and repeated use of enzymes [66]. The stable cata-
lyst cage of a GSB can contain single proteins, but may also
encapsulate multiple components, e.g. sequential enzyme
cascades or tandem reactions [67–71], enzymatic pathways
[72–74] or synthetic gene circuits [75], that can be evolved
directly in this format.
As the GSBs maintain the elements necessary for the
directed evolution of an encapsulated protein, evolvability is
programmed into these constructs (GSBs). The evolved catalyst
is caged in GSBs, where it remains catalytically active and able
to turn over multiple substrate molecules that enter the cage
from the outside. After it has done its job, the caged catalyst
can be removed, stored (e.g. by freezing) and used again.
In the composite GSBs, the functional components are
DNA encoded, so by evolving a caged enzyme, evolvability ofa ‘composite material’ (¼ a functional enzyme in a scaffold)
is demonstrated: each composite carries the functional com-
ponent (the enzyme) together with information that defines
the identity of its functional component (DNA). This type of
evolvability is key to diving further into ‘functional diversity
space’. Where combinatorial approaches exist in materials
science, libraries are usually smaller than screened here
(almost a million members). The combination of the ability to
decode a single species, extreme miniaturization (to pl dro-
plets) and extremely straightforward screening/sorting in a
commercial flow cytometer, provides the basis for easy access
to molecular diversity, increasing the chances of success
and setting the scene for more ambitious searches for novel
functional materials.5. Conclusion
The idea of cell compartmentalization is inspiring a range of
practical approaches aimed at making new, functional mol-
ecules by Darwinian evolution. The extension of evolutionary
principles that are enabled by the compartmentalization in its
various guises has the potential to shape our material world
as much as evolution has shaped Nature, with the only differ-
ence that it is up to us to decide for which purpose bioinspired
parts and devices should be used.
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Figure 6. GSBs for directed enzyme evolution [3]. (a) Assembly of GSBs: monodisperse water-in-oil emulsion droplets are produced with a microfluidic emulsion
generator. The aqueous solution from which droplets are derived contains agarose and the polyanion alginate (red zig-zag line) that gelates upon cooling (from
378C to 48C), so that a solid bead is formed within the droplet template. The droplet boundary is removed by breaking the emulsion in the presence of the
polycation poly(allylamine hydrochloride) (PAH; blue zig-zag line). Upon spontaneous encounter of the anionic alginate and the cationic PAH at the surface of
the agarose template, a polyelectrolyte complex forms that maintains compartmentalization and substitutes the oil/water interface of the former emulsion droplet
with a semipermeable surface layer, functionally resembling a semipermeable cell membrane. (b) Workflow of directed evolution in GSBs: (1) the protein-of-interest
(POI), in this case an enzyme, is expressed in E. coli cells prior to droplet formation. (2) Single cells are then encapsulated into monodisperse water-in-oil emulsion
droplets produced by a microfluidic emulsion generator (with Poisson distribution governing the occupancy). (3) Within the droplet, cells are lysed to allow encoun-
ter with reagents and substrate: now the enzymatic reaction can take place during an incubation period. (4) The gel-droplet emulsion is broken, or de-emulsified, in
the presence of PAH to form the semipermeable polyelectrolyte shell layer, (5) GSBs harbouring active enzyme are distinguished from those with inactive enzyme
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